快速诊断市场规模、份额和成长分析（按产品、平台、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，快速诊断市场规模将达到 441.2 亿美元，到 2025 年将达到 534.7 亿美元，到 2033 年将达到 2489.8 亿美元，在预测期（2026-2033 年）内，复合年增长率为 21.2%。

全球感染疾病和慢性病的日益流行，以及对更高品质诊断解决方案需求的不断增长，预计将推动快速诊断市场的发展。对创新诊断技术的大量投资有望为该领域的营运商开闢新的机会。此外，即时检测的广泛应用以及人们对家庭诊断日益增长的兴趣，也可能进一步推动市场成长。政府旨在意识提升和推进快速检测调查方法的倡议，预计也将对快速诊断公司的收入产生积极影响。然而，高昂的产品成本、熟练专业人员短缺、严格的法规结构以及供应链限制等挑战，可能会阻碍快速诊断的广泛应用。

快速诊断市场驱动因素

全球感染疾病率的不断上升推动了对更先进诊断方法的需求。快速诊断检测能够及早发现这些疾病，有助于在早期阶段有效预防大规模疫情爆发。这种快速检测感染疾病的能力在降低大规模流行病的风险方面发挥关键作用。此外，人们对感染疾病的认识不断提高，以及对及时诊断重要性的认识不断增强，也推动了对快速诊断解决方案的需求。因此，快速诊断市场正在经历显着成长，以满足应对感染疾病威胁所需的高效医疗解决方案的迫切需求。

快速诊断市场的限制因素

由于政府机构和监管机构的严格规定，快速诊断市场面临巨大的挑战。这些规定要求提供全面的文件和详尽的测试通讯协定。这种严苛的合规流程可能会为该领域的企业带来许多不便，导致延误，并阻碍其快速将创新产品推向市场。因此，这些监管障碍可能会减缓整个快速诊断市场的成长前景，并使企业难以顺利通过核准流程，最终影响企业的营运效率和市场动态。

快速诊断市场趋势

将人工智慧 (AI) 应用于快速诊断正成为一项关键的市场趋势，它将显着提高疾病检测的准确性和效率。企业采用 AI 技术为预测分析开闢了道路，从而能够更早诊断各种健康状况。医疗保健行业的快速数位化进一步加速了这一趋势，简化了流程并推动了诊断解决方案的创新。随着相关人员适应这些进步，对 AI 驱动的诊断工具的需求预计将会增长，使其成为个人化医疗的重要组成部分，并在不断变化的医疗保健环境中改善患者的治疗效果。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球快速诊断市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 传染病检查
  • 呼吸道传染病检查产品
  • 流感
  • 肝炎
  • HIV
  • 其他传染病检查
• 血糖监测
• 心血管代谢检测
• 血液凝固检验产品
• 妊娠和不孕症检查
• 肿瘤/癌症标记检测产品
• 尿液检查产品
• 胆固醇检测产品
• 血液检测产品
• 药物滥用检测产品
• 大便潜血试验产品
• 其他产品

全球快速诊断市场规模（按购买类型和复合年增长率划分）（2026-2033 年）

• OTC
• 基于处方笺的检测

全球快速诊断市场规模（依技术及复合年增长率划分）（2026-2033 年）

• 流通式
• 固相法
• 侧向流
• 凝集反应
• 其他技术

全球快速诊断市场规模（按分销管道划分）及复合年增长率（2026-2033 年）

• 医院药房
• 实体店面
• 电子商务
• 其他分销管道

全球快速诊断市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 诊断中心
• 居家医疗环境
• 医院药房
• 其他最终用户

全球快速诊断市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Abbott Laboratories（USA）
• Roche Diagnostics（Switzerland）
• Danaher（USA）
• Siemens Healthineers（Germany）
• Johnson & Johnson（USA）
• Thermo Fisher Scientific（USA）
• BD（Becton, Dickinson and Company）（USA）
• QuidelOrtho（USA）
• Bio-Rad Laboratories（USA）
• Hologic（USA）
• Cepheid（USA）
• Ortho Clinical Diagnostics（USA）
• Siemens Healthineers（Germany）
• Sysmex（Japan）
• Fujifilm Holdings（Japan）
• DiaSorin（Italy）
• BioMerieux（France）
• Instrumentation Laboratory（USA）

结论与建议

Rapid Diagnostics Market size was valued at USD 44.12 Billion in 2024 and is poised to grow from USD 53.47 Billion in 2025 to USD 248.98 Billion by 2033, growing at a CAGR of 21.2% during the forecast period (2026-2033).

The increasing prevalence of infectious and chronic diseases globally, coupled with a rising demand for superior diagnostic solutions, is anticipated to propel the rapid diagnostics market. Significant investments in innovative diagnostic technologies promise to unlock new avenues for providers in this sector. Furthermore, the growing trend of point-of-care testing and the heightened interest in home-based diagnostics are likely to further drive market growth. Government initiatives aimed at enhancing awareness of early detection and advancing rapid testing methodologies are also projected to contribute positively to revenue streams for rapid diagnostics companies. However, challenges such as high product costs, a shortage of skilled professionals, stringent regulatory frameworks, and supply chain limitations may hinder the widespread adoption of rapid diagnostics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Rapid Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Rapid Diagnostics Market Segments Analysis

Global Rapid Diagnostics Market is segmented by Product, Purchase, Technology, Distribution Channel, End Use and region. Based on Product, the market is segmented into Infectious Disease Testing, Glucose Monitoring,Cardiometabolic Exercise Testing, Coagulation Testing Products, Pregnancy And Fertility Testing, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drug-Of-Abuse (DOA) Testing Products, Fecal Occult Testing Products and Other Products. Based on Purchase, the market is segmented into OTC and Prescription-Based Tests. Based on Technology, the market is segmented into Flow-Through, Solid Phase, Lateral Flow, Agglutination Assays and Other Technologies. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Brick & Mortar, E-Commerce and Other Distribution Channels. Based on End Use, the market is segmented into Diagnostic Centers, Homecare Settings, Hospital Pharmacies and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Rapid Diagnostics Market

The growing incidence of infectious diseases globally has led to an escalating demand for improved diagnostic methods. Rapid diagnostic tests facilitate the early identification of these diseases, effectively aiding in the prevention of widespread outbreaks during their initial phases. This ability to swiftly detect infections plays a crucial role in mitigating the risk of large-scale pandemics. Additionally, the increasing awareness surrounding infectious diseases and the importance of timely diagnosis is driving the demand for rapid diagnostic solutions. As a result, the rapid diagnostics market is experiencing significant growth, responding to the urgent need for efficient healthcare solutions in addressing infectious threats.

Restraints in the Rapid Diagnostics Market

The rapid diagnostics market faces significant challenges due to stringent regulations imposed by governmental bodies and regulatory authorities, which require comprehensive documentation and extensive testing protocols. This rigorous compliance process can be cumbersome for companies in the field, resulting in delays and hindering their ability to bring innovations to market swiftly. As a result, these regulatory hurdles may dampen the overall growth prospects of the rapid diagnostics market, making it difficult for companies to navigate the approval landscape and ultimately affecting their operational efficiency and market dynamics.

Market Trends of the Rapid Diagnostics Market

The integration of artificial intelligence in rapid diagnostics is emerging as a pivotal market trend, significantly enhancing both accuracy and efficiency in disease detection. As companies harness AI technologies, they unlock opportunities for predictive analytics, enabling earlier diagnosis of various health conditions. This trend is further fueled by the rapid digitization of the healthcare landscape, which is streamlining processes and driving innovation in diagnostic solutions. As stakeholders adapt to these advancements, the demand for AI-powered diagnostic tools is likely to grow, positioning them as essential components in personalized medicine and improving patient outcomes in a dynamic healthcare environment.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Rapid Diagnostics Market Size by Product & CAGR (2026-2033)

• Market Overview
• Infectious Disease Testing
  • Respiratory Infection Testing Products
  • Influenza
  • Hepatitis
  • HIV
  • Other Infectious Disease Tests
• Glucose Monitoring
• Cardiometabolic Testing
• Coagulation Testing Products
• Pregnancy And Fertility Testing
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drug-Of-Abuse (DOA) Testing Products
• Fecal Occult Testing Products
• Other Products

Global Rapid Diagnostics Market Size by Purchase & CAGR (2026-2033)

• Market Overview
• OTC
• Prescription-Based Tests

Global Rapid Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Flow-Through
• Solid Phase
• Lateral Flow
• Agglutination Assays
• Other Technologies

Global Rapid Diagnostics Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Hospital Pharmacies
• Brick & Mortar
• E-Commerce
• Other Distribution Channels

Global Rapid Diagnostics Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Diagnostic Centers
• Homecare Settings
• Hospital Pharmacies
• Other End Users

Global Rapid Diagnostics Market Size & CAGR (2026-2033)

• North America (Product, Purchase, Technology, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Product, Purchase, Technology, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Purchase, Technology, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Purchase, Technology, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Purchase, Technology, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche Diagnostics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BD (Becton, Dickinson and Company) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cepheid (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ortho Clinical Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioMerieux (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations